Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 32,915

Sort by:

Xlinked hypophosphatemia (XLH) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Xlinked hypophosphatemia (XLH)- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-d...

January 2022 200 pages

Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Xlinked Severe Combined Immunodeficiency (SCID) - Epidemiology Forecast to 2032' report delivers an in-depth unde...

January 2022 60 pages

Xlinked Severe Combined Immunodeficiency (SCID) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Xlinked Severe Combined Immunodeficiency (SCID)- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Yellow Fever - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Yellow Fever - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Yellow Fever - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Yellow Fever- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding...

January 2022 200 pages

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Zollinger Ellison Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Zollinger-Ellison Syndrome - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Zollinger-Ellison Syndrome- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Global Active Pharmaceutical Ingredient (API) Market – Analysis By Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), By Application, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

US$ 2,400.00

Executive The global Active Pharmaceutical Ingredients (API) Market was valued at USD 179.6 Billion in the year 2020. Growth opportunities for the Active Pharmaceutical Ingredient market is attributed...

December 2021 230 pages

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute M...

December 2021 4011 pages

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

US$ 2,500.00

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degenerati...

December 2021 1196 pages

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021

US$ 3,500.00

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Alpha 2C Adr...

December 2021 55 pages

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021

US$ 3,500.00

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC...

December 2021 62 pages

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocar...

December 2021 2359 pages

Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Int...

December 2021 335 pages

Colon Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Colon Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Drugs In Development, 2021, provides an...

December 2021 1498 pages

Dengue Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Dengue Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever – Drugs In Development, 2021, pr...

December 2021 203 pages

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis –...

December 2021 44 pages

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathie...

December 2021 96 pages

Female Contraception (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Contraception (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Drugs In...

December 2021 128 pages

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021

US$ 2,000.00

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction –...

December 2021 90 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipe...

December 2021 88 pages

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Drugs...

December 2021 3486 pages

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy – Drugs In Develo...

December 2021 117 pages

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcar...

December 2021 45 pages

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia – Drugs In Development, 2021,...

December 2021 34 pages

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia – Drugs In Development,...

December 2021 85 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosph...

December 2021 75 pages

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Vir...

December 2021 114 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021

US$ 3,500.00

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 SUMMARY Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) pipeline Target constitutes close to 12 mol...

December 2021 77 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021

US$ 3,500.00

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma...

December 2021 90 pages

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021

US$ 3,500.00

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021 SUMMARY Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) – Interleukin-7 receptor is a protein...

December 2021 65 pages

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer)...

December 2021 4110 pages

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021

US$ 3,500.00

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Leptin Receptor – Drugs In Development, 2021'; Leptin Receptor...

December 2021 58 pages

Medulloblastoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma – Drugs In Development, 2021, provid...

December 2021 556 pages

Meningitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provid...

December 2021 89 pages

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma – Drugs In Development,...

December 2021 1010 pages

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021

US$ 3,500.00

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021 SUMMARY Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 7 mo...

December 2021 44 pages

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respir...

December 2021 179 pages

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease)...

December 2021 2980 pages

Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Drugs In Development,...

December 2021 1317 pages

Ovarian Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides...

December 2021 5066 pages

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Nerve S...

December 2021 567 pages

Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021

US$ 2,000.00

Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pituitary...

December 2021 43 pages

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Drugs In Development, 2021,...

December 2021 104 pages

Presbyopia (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Presbyopia (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia – Drugs In Development, 2021, provides an...

December 2021 78 pages

Prosthetic joint infections (Musculoskeletal) - Drugs in Development, 2021

US$ 2,000.00

Prosthetic joint infections (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prosthetic Joint infections – Dru...

December 2021 80 pages

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Malignant Glioma – Drugs In Dev...

December 2021 56 pages

Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021

US$ 2,500.00

Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retiniti...

December 2021 318 pages

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021

US$ 3,500.00

Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY According to the recently published report 'SerineThreoni...

December 2021 44 pages

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021

US$ 3,500.00

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021 SUMMARY Smoothened Homolog (Protein Gx or SMO) – Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates w...

December 2021 91 pages

Filters

Clear all